Obalon Therapeutics, Inc.
ReShape Lifesciences is a leading weight-loss solutions company dedicated to managing and treating obesity and metabolic diseases through an integrated portfolio of proven products and services. The company develops minimally invasive, non-surgical devices and programs, including the FDA-approved Dual Balloon System, to provide effective weight management options for patients worldwide. Their mission is to address the global obesity epidemic by offering safe, effective, and sustainable therapies that facilitate long-term health improvements.
Industries
Nr. of Employees
small (1-50)
Obalon Therapeutics, Inc.
7625 Golden Triangle Drive, Suite G, Eden Prairie, MN 55344
Patents
Products
Temporary intragastric dual-balloon system (endoscopically delivered)
A two-balloon, endoscopically delivered intragastric system inflated with saline and designed to occupy gastric volume for up to six months while preserving native anatomy; includes design elements to reduce migration risk and a coaching program to support sustained weight loss.
Removable laparoscopic gastric wrap (vest)
A laparoscopically implanted, removable gastric wrap intended to emulate gastric volume reduction effects without permanent anatomical resection.
Adjustable gastric banding system (laparoscopic adjustable gastric band)
An adjustable gastric band product and associated program for long-term weight-loss management delivered via laparoscopic placement.
Calibration tubes and procedural accessories
Clinical accessories to assist in bariatric procedures and device implantation/assessment.
Temporary intragastric dual-balloon system (endoscopically delivered)
A two-balloon, endoscopically delivered intragastric system inflated with saline and designed to occupy gastric volume for up to six months while preserving native anatomy; includes design elements to reduce migration risk and a coaching program to support sustained weight loss.
Removable laparoscopic gastric wrap (vest)
A laparoscopically implanted, removable gastric wrap intended to emulate gastric volume reduction effects without permanent anatomical resection.
Adjustable gastric banding system (laparoscopic adjustable gastric band)
An adjustable gastric band product and associated program for long-term weight-loss management delivered via laparoscopic placement.
Calibration tubes and procedural accessories
Clinical accessories to assist in bariatric procedures and device implantation/assessment.
Services
Remote coaching program providing nutrition, exercise and behavior-modification support for patients undergoing weight-loss therapies.
Instructor-led courses and live-surgery training to support clinical adoption of minimally invasive bariatric devices and procedures.
Services and internal capabilities to prepare PMA submissions, run pivotal randomized trials, and liaise with regulatory authorities for high-risk implantable devices.
Remote coaching program providing nutrition, exercise and behavior-modification support for patients undergoing weight-loss therapies.
Instructor-led courses and live-surgery training to support clinical adoption of minimally invasive bariatric devices and procedures.
Services and internal capabilities to prepare PMA submissions, run pivotal randomized trials, and liaise with regulatory authorities for high-risk implantable devices.
Expertise Areas
- Endoscopic bariatric device therapy
- Minimally invasive bariatric surgical devices
- Randomized pivotal clinical trial execution for devices
- FDA PMA regulatory pathway and device labeling
Key Technologies
- Endoscopic device deployment
- Intragastric dual-balloon systems
- Laparoscopic removable gastric wrap
- Saline-fill with dye leak-detection for implants
News & Updates
The merger of ReShape Lifesciences and Obalon Therapeutics enhances the company's portfolio and market reach.
Data from Spain shows excellent and sustained weight loss with the Dual Balloon system.
The trial demonstrated significant weight loss and safety profile for the ReShape procedure.
The FDA has approved the ReShape Dual Balloon, a non-surgical, temporary device for weight loss in adults with BMI 30-40.
The device is designed to occupy space in the stomach to promote satiety without altering stomach anatomy.
FDA Approval of ReShape Dual Balloon System
First-of-its-kind non-surgical weight loss device approved by the FDA for adults with BMI 30-40.
The merger of ReShape Lifesciences and Obalon Therapeutics enhances the company's portfolio and market reach.
Data from Spain shows excellent and sustained weight loss with the Dual Balloon system.
The trial demonstrated significant weight loss and safety profile for the ReShape procedure.
The FDA has approved the ReShape Dual Balloon, a non-surgical, temporary device for weight loss in adults with BMI 30-40.
The device is designed to occupy space in the stomach to promote satiety without altering stomach anatomy.
FDA Approval of ReShape Dual Balloon System
First-of-its-kind non-surgical weight loss device approved by the FDA for adults with BMI 30-40.